WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ:TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics (TM), today announced that J. Donald deBethizy, Ph.D., President and Chief Executive Officer, is scheduled to present at the Deutsche Bank 33rd Annual Health Care Conference at The InterContinental in Boston, on Wednesday, May 7, 2008 at 8:10 a.m. Eastern Daylight Time.
